The value of decentralized clinical trials: Inclusion, accessibility, and innovation
Science · 23.08.2024 · 385 (6711)
DOI: 10.1126/science.adq4994 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science, erschienen am 23.08.2024. Verfasst von Girardin Jean-Louis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
In this Review, we explore the transformative potential of decentralized clinical trials (DCTs) in addressing the limitations of traditional randomized controlled trials (RCTs). We highlight the merits of DCTs fostering greater inclusivity, efficiency, and adaptability. We emphasize the challenges of RCTs, including limited participant diversity and logistical barriers, geographical constraints, and mistrust in research institutions, showing how DCTs are preferred in addressing these challenges by utilizing remote digital technologies and community providers to enable broader, more inclusive participation. Furthermore, we underscore the potential of DCTs for democratizing clinical research. We also stress the importance of addressing unresolved challenges, including data security and privacy, remote patient monitoring, and regulatory variations. Research is needed to devise standardized protocols to streamline DCT processes, explore its long-term impacts on patient outcomes, and overcome challenges through equitable stakeholder engagement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Neurology, Psychology, and Public Health, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Informatics and Health Data Science, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
ORCID-Profile: Girardin Jean-Louis, Azizi A Seixas
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
Zitieren
APA
Jean-Louis, G., & Seixas, A. A. (2024). The value of decentralized clinical trials: Inclusion, accessibility, and innovation. Science, 385(6711). https://doi.org/10.1126/science.adq4994
Vancouver
Jean-Louis G, Seixas AA. The value of decentralized clinical trials: Inclusion, accessibility, and innovation. Science. 2024;385(6711). doi:10.1126/science.adq4994
BibTeX
@article{JeanLouis2024,
author = {Jean-Louis, Girardin and Seixas, Azizi A},
title = {The value of decentralized clinical trials: Inclusion, accessibility, and innovation},
journal = {Science},
year = {2024},
volume = {385},
number = {6711},
doi = {10.1126/science.adq4994}
}
EUVIMED